Court Refuses To Reclassify Allergan's Restasis As Non-Antibiotic
The U.S. District Court for the District of Columbia has dismissed a lawsuit by drug maker Allergan, Inc., which sought to overturn the U.S. Food and Drug Administration's classification of Restasis...To view the full article, register now.
Already a subscriber? Click here to view full article